Evidence map›Paper›PMID 31667620›Full record

GuidelinePediatric nephrology (Berlin, Germany)2020

The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.

Louise McAlister, Pearl Pugh, Laurence Greenbaum, Dieter Haffner, Lesley Rees, Caroline Anderson, An Desloovere, Christina Nelms, Michiel Oosterveld, Fabio Paglialonga and 8 more

Registry-linked trialOpen access · hybridAbstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Pediatric nephrology (Berlin, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05439980 (Development of Effective Resources for Phosphate Education for Children and Families With Chronic Kidney Disease), which is not on this map. Cited by 54 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 5 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05439980 unknown statusnot on this mapstarted 2023, after this paper: background citation

Development of Effective Resources for Phosphate Education for Children and Families With Chronic Kidney Disease: Hearing the Patient Voice

TypeobservationalSponsorGreat Ormond Street Hospital for Children NHS Foundation TrustRan2023 to 2024Enrolled100ConditionsChronic Kidney Diseases, Hyperphosphatemia, Pediatric Kidney Disease, CKD-MBDArmsKnowledge questionnaire, Focus groups
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 5 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Guideline
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives.Journal of the American Society of Nephrology : JASN · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 8 countries.

Louise McAlisterGreat Ormond Street Hospital for Children NHS Foundation Trust, and University College London, Institute of Child Health, WC1N 3JH, London, UK.
Pearl PughNottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Laurence GreenbaumEmory University and Children's Healthcare of Atlanta, Atlanta, USA.
Dieter HaffnerChildren's Hospital, Hannover Medical School, Hannover, Germany.
Lesley ReesGreat Ormond Street Hospital for Children NHS Foundation Trust, and University College London, Institute of Child Health, WC1N 3JH, London, UK.
Caroline AndersonSouthampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
An DesloovereUniversity Hospital Ghent, Ghent, Belgium.
Christina NelmsPedsFeeds LLC, University of Nebraska, Nebraska, USA.
Michiel OosterveldEmma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Fabio PaglialongaFondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.
Nonnie PoldermanBritish Columbia Children's Hospital, Vancover, Canada.
Leila QizalbashGreat Northern Children's Hospital, Newcastle upon Tyne, UK.
José Renken-TerhaerdtWilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Jetta TuokkolaChildren's Hospital and Clinical Nutrition Unit, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Bradley WaradyChildren's Mercy Kansas City, Kansas City, USA.
Johan Vande WalleUniversity Hospital Ghent, Ghent, Belgium.
Vanessa ShawGreat Ormond Street Hospital for Children NHS Foundation Trust, and University College London, Institute of Child Health, WC1N 3JH, London, UK.
Rukshana ShroffGreat Ormond Street Hospital for Children NHS Foundation Trust, and University College London, Institute of Child Health, WC1N 3JH, London, UK. Rukshana.Shroff@gosh.nhs.uk.ORCID http://orcid.org/0000-0001-8501-1072
Great Ormond Street Hospital for Children NHS Foundation Trust · GBGhent University Hospital · BEBC Children's Hospital · CAChildren's Mercy Hospital · USEmma Kinderziekenhuis · NLEmory University · USFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITGreat North Children's Hospital · GBMedizinische Hochschule Hannover · DENottingham University Hospitals NHS Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity Medical Center Utrecht · NLUniversity of Helsinki · FIUniversity of Nebraska–Lincoln · US

Funding

Department of Health CDF-2016-09-038
6 · The paper itself

Abstract

In children with chronic kidney disease (CKD), optimal control of bone and mineral homeostasis is essential, not only for the prevention of debilitating skeletal complications and achieving adequate growth but also for preventing vascular calcification and cardiovascular disease. Complications of mineral bone disease (MBD) are common and contribute to the high morbidity and mortality seen in children with CKD. Although several studies describe the prevalence of abnormal calcium, phosphate, parathyroid hormone, and vitamin D levels as well as associated clinical and radiological complications and their medical management, little is known about the dietary requirements and management of calcium (Ca) and phosphate (P) in children with CKD. The Pediatric Renal Nutrition Taskforce (PRNT) is an international team of pediatric renal dietitians and pediatric nephrologists, who develop clinical practice recommendations (CPRs) for the nutritional management of various aspects of renal disease management in children. We present CPRs for the dietary intake of Ca and P in children with CKD stages 2-5 and on dialysis (CKD2-5D), describing the common Ca- and P-containing foods, the assessment of dietary Ca and P intake, requirements for Ca and P in healthy children and necessary modifications for children with CKD2-5D, and dietary management of hypo- and hypercalcemia and hyperphosphatemia. The statements have been graded, and statements with a low grade or those that are opinion-based must be carefully considered and adapted to individual patient needs based on the clinical judgment of the treating physician and dietitian. These CPRs will be regularly audited and updated by the PRNT.

Indexed as

Nutritional RequirementsAdvisory CommitteesCalcium, DietaryChildChild Nutritional Physiological PhenomenaChronic Kidney Disease-Mineral and Bone DisorderHumansHypercalcemiaHyperphosphatemiaHypocalcemiaKidney Failure, ChronicPediatricsPhosphatesRenal DialysisCalcium, DietaryPhosphatesCalciumChildrenChronic kidney disease (CKD)NutritionPhosphate

Identifiers

PMID31667620
PMCPMC6969014
OpenAlexW2982445041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.